Area of research
Molecular Medicine · Applied Microbiology and Biotechnology
Research interest
Research interests include Antibiotic Resistance in Bacteria, Antibiotic Use and Resistance, Antibiotics Pharmacokinetics and Efficacy, and Bacterial Identification and Susceptibility Testing.
Resistance to novel β-lactam/β-lactamase inhibitors among carbapenem-resistant <i>Pseudomonas aeruginosa</i> and clinical implications in the prospective observational <i>Pseudomonas</i> study.
Dissemination of Extended-Spectrum β-Lactamase-Producing Enterobacterales in Organic Fertilizers: A One Health Perspective from Southwestern Colombia
Antimicrobial stewardship interventions reduce the time to the first antibiotic administration in septic patients in ICUs: regional multicenter study in 7 Latin American high-complexity hospitals.
Emergence and dissemination of <i>bla</i><sub>KPC-31</sub> and <i>bla</i><sub>PAC-2</sub> among different species of Enterobacterales in Colombia: a new challenge for the microbiological laboratories.
Current and future options for the treatment of serious infections due to carbapenem-resistant <i>Pseudomonas aeruginosa</i>.
In vitro activity of cefiderocol against a global collection of carbapenem-resistant Pseudomonas aeruginosa with a high level of carbapenemase diversity.
First report of KPC variants conferring ceftazidime-avibactam resistance in Colombia: introducing KPC-197.
Global epidemiology and clinical outcomes of carbapenem-resistant Pseudomonas aeruginosa and associated carbapenemases (POP): a prospective cohort study
Global epidemiology and clinical outcomes of carbapenem-resistant Pseudomonas aeruginosa and associated carbapenemases (POP): a prospective cohort study.
Clinical Outcomes and Bacterial Characteristics of Carbapenem-resistant <i>Acinetobacter baumannii</i> Among Patients From Different Global Regions
International Epidemiology of Carbapenemase-Producing Escherichia coli.
Rapid Diagnostic Test Value and Implementation in Antimicrobial Stewardship Across Low-to-Middle and High-Income Countries: A Mixed-Methods Review
Molecular Mechanisms of Resistance to Ceftazidime/Avibactam in Clinical Isolates of <i>Enterobacterales</i> and Pseudomonas aeruginosa in Latin American Hospitals.
Rapid Diagnostic Test Value and Implementation in Antimicrobial Stewardship Across Low-to-Middle and High-Income Countries: A Mixed-Methods Review.
Activity of novel β-lactam/β-lactamase inhibitor combinations against serine carbapenemase-producing carbapenem-resistant <i>Pseudomonas aeruginosa</i>
Antimicrobial stewardship programs in seven Latin American countries: facing the challenges.
Antimicrobial Stewardship Programs in Latin America and the Caribbean: A Story of Perseverance, Challenges, and Goals.
Identification of <i>mcr-1</i> Genes and Characterization of Resistance Mechanisms to Colistin in <i>Escherichia coli</i> Isolates from Colombian Hospitals.
Update of antimicrobial resistance in level III and IV health institutions in Colombia between January 2018 and December 2021
Gaps and barriers in the implementation and functioning of antimicrobial stewardship programmes: results from an educational and behavioural mixed-methods needs assessment in France, the United States, Mexico and India-authors' response.
Clinical outcomes and bacterial characteristics of carbapenem-resistant Klebsiella pneumoniae complex among patients from different global regions (CRACKLE-2): a prospective, multicentre, cohort study.
Clinical data from studies involving novel antibiotics to treat multidrug-resistant Gram-negative bacterial infections
Early appropriate diagnostics and treatment of MDR Gram-negative infections.
Impact of antimicrobial stewardship programs on antibiotic consumption and antimicrobial resistance in four Colombian healthcare institutions.
Phenotypic and genotypic profile of ceftolozane/tazobactam-non-susceptible, carbapenem-resistant Pseudomonas aeruginosa.
Global resilience and new strategies needed for antimicrobial stewardship during the COVID-19 pandemic and beyond.
Molecular mechanisms leading to ceftolozane/tazobactam resistance in clinical isolates of <i>Pseudomonas aeruginosa</i> from five Latin American countries.
Multicenter, Prospective Validation of a Phenotypic Algorithm to Guide Carbapenemase Testing in Carbapenem-Resistant <i>Pseudomonas aeruginosa</i> Using the ERACE-PA Global Surveillance Program.
Comparative In Vitro Activity of Ceftolozane/Tazobactam against Clinical Isolates of <i>Pseudomonas aeruginosa</i> and <i>Enterobacterales</i> from Five Latin American Countries.
Gaps and barriers in the implementation and functioning of antimicrobial stewardship programmes: results from an educational and behavioural mixed methods needs assessment in France, the United States, Mexico and India.